Eisai is a Tokyo-based corporate venture capital investor backing startups with innovative technology, science and business models that can reinforce its healthcare and pharmaceutical innovation platform. It targets biotechnology, digital technologies and drug development technologies across Biotechnology, HealthTech, Pharmaceuticals, Life Sciences, AI and Machine Learning, and Data. Eisai invests in the United States and has acted as a lead investor in a seed financing.